Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition

Experimental and Molecular Pathology

Volumn 89, Issue 3, 2010, Pages 209-216

  Jahn, Jennifer E ^a   Best, D Hunter ^a   Coleman, William B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatocellular carcinoma; Human 11p11.2; Mesenchymal to epithelial transition (MET); Synaptotagmin; Wilm's tumor 1 (Wt1)

Indexed keywords

MESSENGER RNA; SYNAPTOTAGMIN; SYNAPTOTAGMIN 13; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CELL DIFFERENTIATION; CHROMOSOME 11; CONTACT INHIBITION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; IN VITRO STUDY; LIVER CELL CARCINOMA; NEPHROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; RAT; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 11; EPITHELIAL-MESENCHYMAL TRANSITION; GENES, TUMOR SUPPRESSOR; HUMANS; HYBRID CELLS; LIVER NEOPLASMS; PHENOTYPE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNAPTOTAGMINS; TRANSFECTION;

GASTROPODA; RATTUS;

EID: 78249288132     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.09.001     Document Type: Article

References (36)

1. Banerjee A., et al. Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13. Cancer Res. 1992, 52:6297-6304.
2. Batlle E., et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2:84-89.
3. Boige V., et al. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res. 1997, 57:1986-1990.
4. Coleman W.B., et al. Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2-p12 region of human chromosome 11. Mol. Carcinog. 1995, 13:220-232.
5. Coleman W.B., et al. Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines. Mol. Carcinog. 1997, 19:267-272.
6. Coleman W.B., et al. Induction of rat WT1 gene expression correlates with human chromosome 11p11.2-p12-mediated suppression of tumorigenicity in rat liver epithelial tumor cell lines. Int. J. Oncol. 1999, 14:957-963.
7. Friederichs J., et al. Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Int. J. Colorectal Dis. 2005, 20:391-402.
8. Fujimori M., et al. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 1991, 51:89-93.
9. Fukuda M., Mikoshiba K. Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII). Biochem. J. 2001, 354:249-257.
10. Fukuda M., et al. Mechanism of the SDS-resistant synaptotagmin clustering mediated by the cysteine cluster at the interface between the transmembrane and spacer domains. J. Biol. Chem. 2001, 276:40319-40325.
11. Garcia M., et al. Global Cancer Facts & Figures 2007 2007, Atlanta, GA, American Cancer Society.
12. Gronborg M., et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 2006, 5:157-171.
13. Hohenstein P., Hastie N.D. The many facets of the Wilms' tumour gene, WT1. Hum. Mol. Genet. 2006, 15:R196-R201.
14. Hosono S., et al. WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene 1999, 18:417-427.
15. Hosono S., et al. E-cadherin is a WT1 target gene. J. Biol. Chem. 2000, 275:10943-10953.
16. Huber M.A., et al. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005, 17:548-558.
17. Jahn J.E., Coleman W.B. Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line. Int. J. Oncol. 2008, 32:441-449.
18. Jahn J.E., et al. Identification of candidate liver tumor suppressor genes from human 11p11.2 by transcription mapping of microcell hybrid cell lines. Int. J. Oncol. 2003, 22:1303-1310.
19. Lee L.W., et al. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells. Cancer Res. 1991, 51:5238-5244.
20. Luo X.N., et al. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene 1995, 11:743-750.
21. Mahon M.C., et al. Suppression of tumorigenicity of rat liver epithelial tumor cell lines by a putative human 11p11.2-p12 liver tumor suppressor locus. Int. J. Oncol. 1999, 14:337-346.
22. Miwa H., et al. RNA expression of the WT1 gene in Wilms' tumors in relation to histology. J. Natl Cancer Inst. 1992, 84:181-187.
23. Nagai H., et al. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997, 14:2927-2933.
24. Parkin D.M., et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
25. Piao Z., et al. Allelotype analysis of hepatocellular carcinoma. Int. J. Cancer 1998, 75:29-33.
26. Pritchard-Jones K., et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990, 346:194-197.
27. Ricketts S.L., et al. Identification of candidate liver tumor suppressor genes from human 11p11.2-p12. Genes Chromosom. Cancer 2002, 33:47-59.
28. Ricketts S.L., et al. Identification of three 11p11.2 candidate liver tumor suppressors through analysis of known human genes. Mol. Carcinog. 2003, 36:90-99.
29. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001, 23:912-923.
30. Saxon P.J., et al. Selective transfer of individual human chromosomes to recipient cells. Mol. Cell. Biol. 1985, 5:140-146.
31. Schmidt C.R., et al. E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells. Surgery 2005, 138:306-312.
32. Steadman J.S., et al. DNA contents and chromosomes of clonal lines of transformed rat liver epithelial cells and of cells from their derived tumors. Carcinogenesis 1994, 15:963-969.
33. Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002, 31:339-346.
34. Tsao M.S., Grisham J.W. Phenotypic modulation during tumorigenesis by clones of transformed rat liver epithelial cells. Cancer Res. 1987, 47:1282-1286.
35. Tsao M.S., et al. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp. Cell Res. 1984, 154:38-52.
36. von Poser C., Sudhof T.C. Synaptotagmin 13: Structure and expression of a novel synaptotagmin. Eur. J. Cell Biol. 2001, 80:41-47.